| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
195,811,000 |
| Market
Cap: |
1.32(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.08 - $6.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
155,000 |
191,958 |
| Total Buy Value |
$0 |
$0 |
$579,644 |
$685,344 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
1,500,000 |
1,500,000 |
4,083,538 |
4,083,538 |
| Total Sell Value |
$9,143,159 |
$9,143,159 |
$19,811,348 |
$19,811,348 |
| Total People Sold |
1 |
1 |
4 |
4 |
| Total Sell Transactions |
5 |
5 |
11 |
11 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lenz Brian |
EVP, CFO |
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
135,175 |
1,041,292 |
|
- |
|
| Grossman Jerrold B |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,815 |
313,265 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-02-28 |
4 |
D |
$3.55 |
$26,650 |
D/D |
(7,507) |
2,010,904 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-02-28 |
4 |
D |
$3.55 |
$17,750 |
D/D |
(5,000) |
906,117 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-02-25 |
4 |
D |
$3.42 |
$63,031 |
D/D |
(18,430) |
2,018,411 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-02-25 |
4 |
D |
$3.42 |
$32,442 |
D/D |
(9,486) |
911,117 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2022-12-09 |
4 |
B |
$2.86 |
$42,849 |
I/I |
14,982 |
1,143,426 |
0.01 |
1% |
|
| Grossman Adam S |
President and CEO |
• • – |
2022-12-09 |
4 |
B |
$2.86 |
$42,851 |
D/D |
14,983 |
2,203,708 |
0.01 |
1% |
|
| Lenz Brian |
EVP, CFO |
• • – |
2022-12-09 |
4 |
B |
$2.86 |
$20,000 |
D/D |
6,993 |
1,034,825 |
0.01 |
1% |
|
| Lenz Brian |
EVP, CFO |
• • – |
2022-09-30 |
4 |
D |
$2.43 |
$179,038 |
D/D |
(73,678) |
1,027,832 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2022-09-30 |
4 |
D |
$2.43 |
$246,195 |
D/D |
(101,315) |
2,188,725 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2022-05-11 |
4 |
D |
$1.43 |
$100,106 |
D/D |
(70,004) |
2,290,040 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2022-05-11 |
4 |
D |
$1.43 |
$74,310 |
D/D |
(51,965) |
1,101,510 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2022-03-23 |
4 |
D |
$1.46 |
$73,787 |
D/D |
(50,539) |
2,360,044 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2022-03-23 |
4 |
D |
$1.46 |
$54,280 |
D/D |
(37,178) |
1,153,475 |
|
- |
|
| Grossman Jerrold B |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,586 |
287,450 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
137,500 |
1,190,653 |
|
- |
|
| Kwon Young |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,586 |
226,586 |
|
- |
|
| Guiheen Lawrence P. |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,586 |
104,086 |
|
- |
|
| Elms Steve |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,586 |
26,586 |
|
- |
|
| Fong Bryant |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,586 |
34,086 |
|
- |
|
| Demski Martha J |
|
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
I/I |
26,586 |
30,786 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2022-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
2,410,583 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$250,000 |
I/I |
250,000 |
1,128,444 |
0.01 |
38% |
|
| Grossman Adam S |
President and CEO |
• • – |
2021-10-25 |
4 |
B |
$1.00 |
$100,000 |
D/D |
100,000 |
2,137,616 |
0.01 |
38% |
|
222 Records found
|
|
Page 3 of 9 |
|
|
0.07 (1.05%) 
